Fragment-based Drug Discovery

Fragment-based drug discovery is one of the most well-developed approaches for projects starting from small, low-affinity compounds. Powerful biophysical and structural biology tools enable the study of large numbers of fragments and are opening new possibilities in the treatment of various diseases.

WuXi AppTec offers a comprehensive fragment screening platform to support hit-to-lead optimization workflows. Together with our well-seasoned synthetic and medicinal chemistry platform, we incorporate multiple, advanced techniques for an integrated approach to fragment-based drug discovery.